SAN DIEGO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that company management will present in the following upcoming investor conferences in November:

Guggenheim Securities Healthcare Innovation Conference

Monday, November 11, 2024, at 2:30 p.m. ET

Jefferies London Healthcare Conference

Wednesday, November 20, 2024, at 8:30 a.m. GMT

Live webcasts of the presentations will be accessible on the Investor page of Travere's website at ir.travere.com/events-presentations, and replays will be available for up to 30 days following each event.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent - that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope - today and tomorrow. For more information, visit travere.com. 

Contact: Investors:

888-969-7879                                        

IR@travere.com

Media:

888-969-7879                                        

mediarelations@travere.com